Attention Deficit Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Attention Deficit Hyperactivity Disorder stocks.

Attention Deficit Hyperactivity Disorder Stocks Recent News

Date Stock Title
Mar 29 LLY Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
Mar 28 ZVRA Zevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...
Mar 28 ZVRA Zevra Therapeutics: Q4 Earnings Insights
Mar 28 ZVRA Zevra Therapeutics GAAP EPS of -$1.30 misses by $0.12, revenue of $27.46M beats by $1.48M
Mar 28 ZVRA Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Mar 28 LLY Starter Stock Portfolio: 12 Safe Stocks To Invest In Now
Mar 28 LLY 2 Top Biotech Buyout Candidates
Mar 28 LLY 10 Best Growth Stocks To Invest In Now
Mar 28 LLY 13 Hot Stocks to Invest in According to Wall Street Analysts
Mar 28 LLY Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
Mar 28 LLY Insiders Are Dumping These 10 Healthcare Stocks
Mar 28 LLY Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
Mar 28 LLY Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Mar 28 LLY Prediction: This Will Be the Next "Magnificent Seven" Stock
Mar 28 ZVRA Earnings Scheduled For March 28, 2024
Mar 27 LLY Dow Jones Futures Fall On Hawkish Fed; Small Caps Jump As Nvidia, Growth Leaders Skid
Mar 27 DRRX DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript
Mar 27 ZVRA Zevra Therapeutics Q4 2023 Earnings Preview
Mar 27 DRRX Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
Mar 27 DRRX DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

Browse All Tags